Malignant Laryngeal Neoplasm — Trials

Malignant Laryngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

275 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 41
Ph III recruiting: 5
Growth YoY: —
Industry share: 2%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%
Trials / 1,000 deaths: 16.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06039631	Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer	recruiting	Phase 2	82	Fudan UniversityOTHER	1	Sep 15, 2023	clinicaltrials
NCT05375266	Immune Biomarker Study for Head and Neck Cancer(ImmunBio-KHT)	recruiting	—	1,100	University of Erlangen-Nürnberg Medical SchoolOTHER	1	May 17, 2023